Pine Island Acquisition Corp. Announces Partial Exercise and Closing of Underwriters’ Option to Purchase Additional Units in Connection with its Initial Public Offering


FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Pine Island Acquisition Corp. (the “Company”) today announced that the underwriters of its previously announced initial public offering of 20,000,000 units, which closed on November 19, 2020, have partially exercised their option to purchase additional units, resulting in the issuance of an additional 1,838,800 units at a public offering price of $10.00 per unit. After giving effect to the partial exercise and close of the option, an aggregate of 21,838,800 units have been issued in the initial public offering and an aggregate of $218,388,000 has been deposited into the Company’s trust account. The underwriters have until December 31, 2020 to exercise the remainder of their option to purchase additional units.

Each unit consists of one share of the Company’s Class A common stock and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A

Read More

Outdoor exercise still allowed, eating in public curbed in Italian region that includes Aviano AB


Outdoor exercise still allowed, eating in public curbed in Italian region that includes Aviano AB


Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See other free reports here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription.


AVIANO AIR BASE, Italy — Outdoor exercise facilities will remain open following a reversal by Italian authorities, but eating and drinking in public was barred at Aviano following the announcement of new coronavirus restrictions in the Friuli Venezia Giulia region, Italian and Air Force officials said.


The new regional law will last through Dec. 3.


A preliminary version of the new rules were set to suspend activities at sports centers throughout Friuli Venezia Giulia, which has been marked by Italian public health officials as “orange,” denoting a region of medium-high coronavirus risk with elevated restrictions.


However,

Read More

Outdoor exercise still allowed, eating in public curbed in Italian region that includes Aviano AB – Europe


Outdoor exercise still allowed, eating in public curbed in Italian region that includes Aviano AB


Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See other free reports here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription.


AVIANO AIR BASE, Italy — Outdoor exercise facilities will remain open following a reversal by Italian authorities, but eating and drinking in public was barred at Aviano following the announcement of new coronavirus restrictions in the Friuli Venezia Giulia region, Italian and Air Force officials said.


The new regional law will last through Dec. 3.


A preliminary version of the new rules were set to suspend activities at sports centers throughout Friuli Venezia Giulia, which has been marked by Italian public health officials as “orange,” denoting a region of medium-high coronavirus risk with elevated restrictions.


However,

Read More

As coronavirus cases rise, Montgomery County mandates masks in public, lowers cap on gatherings


“We are entering a phase of covid-19 that is very worrisome, and we need every resident to understand what that means,” said Montgomery County health officer Travis Gayles. “The case counts are continuing to rise at an alarming rate, and we need to take more drastic steps to reduce transmission.”

D.C. and Prince George’s County have a 10-person cap on gatherings. In Virginia, 25 people are allowed in gatherings indoors or outdoors.

Ahead of the Thanksgiving holiday, Montgomery County Executive Marc Elrich (D) is also calling on Gov. Larry Hogan (R) to bring the state back to Phase 1 of its reopening.

“[The covid-19 spread] is only going to get worse and worse,” he said Monday evening. “And the things we loosened up contributed to this.”

New daily infections in the county have hit record levels in recent days, climbing to a seven-day average this week of 312 new daily

Read More

Telos Corporation Completes Initial Public Offering and Announces Exercise of Over-Allotment


ASHBURN, Va., Nov. 24, 2020 (GLOBE NEWSWIRE) — Telos® Corporation (“Telos”), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, announced the closing of its upsized initial public offering of 14,968,859 shares of common stock. The offering was priced at $17.00 per share, resulting in gross proceeds of $254,470,603. Telos’s shares began trading on the Nasdaq Global Market on November 19, 2020 under the Ticker Symbol “TLS.”

B. Riley Securities, BMO Capital Markets, and Needham & Company acted as joint bookrunners for the offering. Colliers Securities LLC, D.A. Davidson & Co., Northland Capital Markets, Wedbush Securities, and MKM Partners served as co-managers for the offering. The underwriters yesterday elected to exercise the 30-day option, granted by Telos, to purchase an additional 2,245,328 shares of common stock at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments. After giving effect

Read More

Silver Elephant Announces Closing of C$9.2 Million Bought Deal Public Offering, Including Full Exercise of the Over-Allotment Option – Press Release


Not for distribution to U.S. news wire services or dissemination in the United States.

VANCOUVER, BC / ACCESSWIRE / November 24, 2020 / Silver Elephant Mining Corp. (“Silver Elephant” or the “Company“) (TSX:ELEF)(OTCQX:SILEF)(Frankfurt:1P2N) is pleased to announce the closing of its bought deal short form prospectus offering pursuant to which the Company has issued 23,000,000 common shares of the Company (the “Common Shares“) at a price of C$0.40 per Common Share, for aggregate gross proceeds of C$9,200,000 (the “Offering“), including the full exercise of the over-allotment option.

The Offering was led by Mackie Research Capital Corporation as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters, including Canaccord Genuity Corp. and Sprott Capital Partners LP.

The net proceeds from the Offering will be used for the exploration, development and/or improvement of the Company’s mineral properties and for working capital

Read More

NeoGames Announces Closing of $94.0 Million Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option


LUXEMBOURG, Nov. 24, 2020 (GLOBE NEWSWIRE) — NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the “Company”), a technology-driven provider of end-to-end iLottery solutions, announced today the closing of its initial public offering of 5,528,650 ordinary shares at a price of $17.00 per ordinary share, including 721,128 ordinary shares sold pursuant to the full exercise of the underwriters’ overallotment option. The offering consisted of 2,987,625 ordinary shares offered by the Company and 2,541,025 ordinary shares offered by certain selling shareholders. The shares began trading on The Nasdaq Global Market under the ticker symbol “NGMS” on November 19, 2020.

Stifel acted as the lead bookrunner for the offering and as representative of the underwriters, and Macquarie Capital and Truist Securities acted as joint bookrunners for the offering.

A registration statement on Form F-1 relating to these securities was declared effective by the U.S. Securities and Exchange Commission on November 18, 2020. This offering

Read More

Olema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares


SAN FRANCISCO, Nov. 23, 2020 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced the closing of its previously announced initial public offering of 12,650,000 shares of its common stock, which includes 1,650,000 shares sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares, at a price to the public of $19.00 per share. Including the option exercise, the aggregate gross proceeds to Olema Oncology from the offering were approximately $240.4 million, before deducting the underwriting discounts and commissions and offering expenses. The shares began trading on the Nasdaq Global Select Market on November 19, 2020, under the ticker symbol “OLMA.”

J.P. Morgan Securities LLC, Jefferies LLC and Cowen and Company, LLC acted as active joint book-running managers for the offering. Canaccord Genuity

Read More

Camtek Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option


MIGDAL HAEMEK, Israel, Nov. 23, 2020 /PRNewswire/ — Camtek Ltd. (NASDAQ: CAMT) (TASE: CAMT), a leading manufacturer of metrology and inspection equipment, today announced the closing of its previously announced underwritten public offering of 4,025,000 ordinary shares, which includes the full exercise of the underwriters’ option to purchase 525,000 additional ordinary shares, at a price to the public of $17.00 per share.

The gross proceeds to Camtek from the offering were approximately $68.4 million, before deducting underwriting discounts and commissions and other offering expenses payable by Camtek.

Camtek intends to use the net proceeds from the offering for general corporate purposes, including, but not limited to, potential acquisitions, working capital, capital expenditures, investments, research and development and product development. Camtek has not determined the amount of net proceeds to be used specifically for the foregoing purposes and has no agreements or understandings with respect to any acquisition or

Read More

Olema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares


SAN FRANCISCO, Nov. 23, 2020 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced the closing of its previously announced initial public offering of 12,650,000 shares of its common stock, which includes 1,650,000 shares sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares, at a price to the public of $19.00 per share. Including the option exercise, the aggregate gross proceeds to Olema Oncology from the offering were approximately $240.4 million, before deducting the underwriting discounts and commissions and offering expenses. The shares began trading on the Nasdaq Global Select Market on November 19, 2020, under the ticker symbol “OLMA.”

J.P. Morgan Securities LLC, Jefferies LLC and Cowen and Company, LLC acted as active joint book-running managers for the offering. Canaccord Genuity

Read More